Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial

2023270 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 401, Issue 10377, pp. 645-654

Field-Weighted Citation Impact: 57.60